Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma
Status:
Completed
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
Purpose: To investigate intravitreal aflibercept (IVA) injection as an adjunctive treatment
to trabeculectomy with mitomycin C (TMC) and panretinal photocoagulation (PRP) for
neovascular glaucoma (NVG).
Setting: Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Study
design: Prospective interventional case series Methods: PRP and IVA (2 mg/0.05 ml) injection
were given, and TMC was performed within 2 weeks after IVA. Additional PRP, laser suture
lysis, subconjunctival 5-fluorouracil injection, and bleb needling were performed after TMC
if indicated. Best-collected visual acuity (BCVA), intraocular pressure (IOP), surgical
complications, and number of anti-glaucoma medications were collected.